Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.34%85.04M | -15.74%82.03M | -22.76%82.57M | 9.29%404.39M | -10.82%96.79M | 7.77%91.78M | 32.06%97.35M | 4.19%106.9M | -0.92%370.02M | 24.86%108.53M |
| Cost of revenue | 6.36%379.46M | -0.62%356.77M | ||||||||
| Gross profit | 88.25%24.93M | -8.37%13.24M | ||||||||
| Operating expense | -8.61%18.01M | 2.50%19.71M | ||||||||
| Selling and administrative expenses | ---- | ---- | ---- | -8.49%14.61M | ---- | ---- | ---- | ---- | 3.22%15.97M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -8.49%14.61M | ---- | ---- | ---- | ---- | 3.22%15.97M | ---- |
| Other operating expenses | ---- | ---- | ---- | -9.13%3.4M | ---- | ---- | ---- | ---- | -0.48%3.75M | ---- |
| Operating profit | 271.95%1.97M | -14.43%1.56M | -25.21%1.99M | 206.91%6.92M | 1,259.09%3.57M | 88.82%-1.15M | 336.32%1.82M | -25.01%2.67M | -35.37%-6.47M | 98.03%-308K |
| Net non-operating interest income (expenses) | 6.40%-11.09M | -12.05%-3.08M | 8.06%-2.72M | -36.34%-11.85M | ||||||
| Non-operating interest income | 222.22%145K | 11.36%49K | 4.26%49K | -76.04%195K | -70.20%59K | -76.80%45K | -86.87%44K | -45.98%47K | --814K | --198K |
| Non-operating interest expense | -12.95%2.49M | -21.24%2.46M | -10.13%2.48M | -10.87%11.29M | -31.57%2.55M | 1.28%2.86M | 1.30%3.12M | -9.14%2.76M | 45.70%12.66M | 46.71%3.72M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 155.83%737K | -230.83%-1.32M | ||||||||
| Less:Write off | ---- | ---- | ---- | -155.83%-737K | ---- | ---- | ---- | ---- | 230.83%1.32M | ---- |
| Other non-operating income (expenses) | -55.29%5.07M | -55.50%1.6M | 5.68%1.68M | 7.26%11.34M | ||||||
| Income before tax | 113.03%216K | 80.64%625K | -85.91%229K | 119.67%1.63M | 135.12%1.32M | 85.10%-1.66M | 321.95%346K | -25.66%1.63M | -151.78%-8.3M | 103.79%561K |
| Income tax | 511.11%110K | -131.65%-50K | 201.64%124K | 106.47%204K | 104.05%150K | -71.43%18K | 171.17%158K | -117.26%-122K | -179.15%-3.16M | -498.60%-3.7M |
| Net income | 106.32%106K | 259.04%675K | -93.99%105K | 127.78%1.43M | -72.58%1.17M | 85.02%-1.68M | -38.16%188K | 18.12%1.75M | 29.39%-5.14M | 127.13%4.26M |
| Net income continuous operations | 106.32%106K | 259.04%675K | -93.99%105K | 127.78%1.43M | -72.58%1.17M | 85.02%-1.68M | -38.16%188K | 18.12%1.75M | 29.39%-5.14M | 127.13%4.26M |
| Noncontrolling interests | 37.83%-442K | 139.86%57K | -554.00%-227K | -448.62%-993K | -136.33%-190K | -656.38%-711K | 33.80%-143K | 112.69%50K | -722.73%-181K | 1,146.00%523K |
| Net income attributable to the company | 156.79%548K | 86.71%618K | -80.44%332K | 148.81%2.42M | -63.67%1.36M | 91.30%-965K | -36.35%331K | -9.40%1.7M | 31.67%-4.96M | 123.88%3.74M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 156.79%548K | 86.71%618K | -80.44%332K | 148.81%2.42M | -63.67%1.36M | 91.30%-965K | -36.35%331K | -9.40%1.7M | 31.67%-4.96M | 123.88%3.74M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 157.14%0.0004 | 100.00%0.0004 | -81.82%0.0002 | 148.48%0.0016 | -64.00%0.0009 | 90.67%-0.0007 | -50.00%0.0002 | -15.38%0.0011 | 45.90%-0.0033 | 123.63%0.0025 |
| Diluted earnings per share | 157.14%0.0004 | 100.00%0.0004 | -81.82%0.0002 | 148.48%0.0016 | -64.00%0.0009 | 90.67%-0.0007 | -50.00%0.0002 | -15.38%0.0011 | 45.90%-0.0033 | 123.63%0.0025 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.